Precision medicine in the management of type 2 diabetes
The study of type 2 diabetes has been driven by advances in human genetics, epigenetics, biomarkers, mechanistic studies, and large clinical trials, enabling new insights into disease susceptibility, pathophysiology, progression, and development of complications. Simultaneously, several new drug cla...
Main Authors: | , |
---|---|
Format: | Journal article |
Published: |
Elsevier
2018
|